Dynamics of HBsAg clearance in a UK cohort of chronic HBV infection
Hepatitis B surface antigen (HBsAg) has recently gained traction as a biomarker that may provide prognostic information and inform treatment decisions in chronic hepatitis B virus (HBV) infection. It may be particularly useful when HBV DNA levels are low and therefore difficult to quantify accuratel...
主要な著者: | Downs, L, Patel, M, Ansari, M, McNaughton, A, Smith, D, Andersson, M, Barnes, E, Jeffery, K, Matthews, P |
---|---|
フォーマット: | Conference item |
出版事項: |
Elsevier
2018
|
類似資料
-
The potential effect of HBV vaccination on off-treatment HBsAg reversion after interferon-induced HBsAg clearance
著者:: Shaowen Jiang, 等
出版事項: (2023-01-01) -
Effect of S-region mutations on HBsAg in HBsAg-negative HBV-infected patients
著者:: Hui Liu, 等
出版事項: (2024-04-01) -
Comparison of serum HBsAg quantitation by four immunoassays, and relationships of HBsAg level with HBV replication and HBV genotypes.
著者:: Edouard Tuaillon, 等
出版事項: (2012-01-01) -
Electronic health informatics data to describe clearance dynamics of hepatitis B surface antigen (HBsAg) and e antigen (HBeAg) in chronic hepatitis B virus infection
著者:: Downs, L, 等
出版事項: (2019) -
Investigation of HBV DNA in HBsAg positive patients
著者:: Nihal Secil Bati, 等
出版事項: (2017-12-01)